Enriched clinical annotations |
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched. |
Clinical annotation |
Category |
P-value |
Hits |
Hits(%) |
Module hits in category |
Arrays in annotation |
Arrays |
Liver tissue (Liver cancer*) |
Liver cancer* |
1.6e-75 |
98 |
67.5 |
145 |
187 |
1945 |
Liver tissue, cancer or cell line (Liver cancer*) |
Liver cancer* |
1.5e-72 |
98 |
67.5 |
145 |
197 |
1945 |
Hepatitis infected liver (Liver cancer*) |
Liver cancer* |
1.4e-50 |
75 |
51.7 |
145 |
156 |
1945 |
Cancer and cell line (Liver cancer) |
Liver cancer |
1.4e-15 |
56 |
100 |
56 |
126 |
207 |
Non-tumor liver tissue (Liver cancer) |
Liver cancer |
1.5e-15 |
63 |
64.2 |
98 |
76 |
207 |
Liver tissue, cancer or cell line (Liver cancer*) |
Liver cancer* |
1.7e-14 |
46 |
32.3 |
142 |
197 |
1945 |
Lung tissue, cancer or cell line (Lung cancer*) |
Lung cancer* |
1.9e-09 |
47 |
33.0 |
142 |
276 |
1945 |
Hepatitis infected liver (Liver cancer*) |
Liver cancer* |
3.7e-09 |
33 |
23.2 |
142 |
156 |
1945 |
Liver tissue (Liver cancer*) |
Liver cancer* |
9.6e-09 |
36 |
25.3 |
142 |
187 |
1945 |
Liver cancer cell line (Liver cancer) |
Liver cancer |
1.1e-06 |
10 |
17.8 |
56 |
10 |
207 |
Metastasis (Liver cancer) |
Liver cancer |
1.1e-06 |
10 |
17.8 |
56 |
10 |
207 |
Cancer and cell line (Lung cancer*) |
Lung cancer* |
1.1e-06 |
39 |
27.4 |
142 |
252 |
1945 |
Cancer (Lung cancer*) |
Lung cancer* |
1.1e-06 |
39 |
27.4 |
142 |
252 |
1945 |
Cancer (Liver cancer) |
Liver cancer |
1.4e-06 |
46 |
82.1 |
56 |
115 |
207 |
Lung cancer (Lung cancer*) |
Lung cancer* |
5.8e-06 |
36 |
25.3 |
142 |
238 |
1945 |
Lung cancer or cell line (Lung cancer*) |
Lung cancer* |
5.8e-06 |
36 |
25.3 |
142 |
238 |
1945 |
Cell line (Liver cancer) |
Liver cancer |
9.6e-06 |
10 |
17.8 |
56 |
11 |
207 |
Invasive liver tumor (Liver cancer) |
Liver cancer |
0.0001 |
20 |
35.7 |
56 |
38 |
207 |
Follicular lymphoma (Various tumors) |
Various tumors |
0.0001 |
4 |
57.1 |
7 |
9 |
154 |
Adenocarcinoma (Liver cancer) |
Liver cancer |
0.0001 |
38 |
67.8 |
56 |
97 |
207 |
Normal tissue (Liver cancer) |
Liver cancer |
0.0003 |
13 |
13.2 |
98 |
14 |
207 |
Enriched GO annotations |
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column). |
GO annotation |
P-value |
Hits |
Hits(%) |
Module genes |
Genes in annotation |
Genes |
carboxylic acid metabolism |
1.0e-134 |
81 |
98.7 |
82 |
138 |
4566 |
organic acid metabolism |
2.5e-134 |
81 |
98.7 |
82 |
139 |
4566 |
amine metabolism |
5.3e-31 |
21 |
25.6 |
82 |
31 |
4566 |
catalytic activity |
7.5e-27 |
76 |
92.6 |
82 |
1677 |
4566 |
carboxylic acid catabolism |
2.4e-25 |
19 |
23.1 |
82 |
35 |
4566 |
amino acid and derivative metabolism |
1.0e-24 |
17 |
20.7 |
82 |
26 |
4566 |
oxidoreductase activity |
2.1e-23 |
35 |
42.6 |
82 |
254 |
4566 |
fatty acid metabolism |
7.5e-22 |
20 |
24.3 |
82 |
57 |
4566 |
electron transporter activity |
2.6e-20 |
33 |
40.2 |
82 |
269 |
4566 |
organic acid biosynthesis |
1.3e-18 |
15 |
18.2 |
82 |
33 |
4566 |
carboxylic acid biosynthesis |
2.4e-18 |
15 |
18.2 |
82 |
34 |
4566 |
aldehyde metabolism |
1.2e-15 |
9 |
10.9 |
82 |
10 |
4566 |
lipid catabolism |
3.2e-14 |
12 |
14.6 |
82 |
30 |
4566 |
amino acid metabolism |
1.4e-13 |
20 |
24.3 |
82 |
139 |
4566 |
eicosanoid metabolism |
1.6e-13 |
10 |
12.1 |
82 |
19 |
4566 |
fatty acid beta-oxidation |
3.3e-13 |
8 |
9.7 |
82 |
10 |
4566 |
fatty acid oxidation |
3.3e-13 |
8 |
9.7 |
82 |
10 |
4566 |
lipid metabolism |
2.9e-12 |
19 |
23.1 |
82 |
143 |
4566 |
aromatic amino acid family metabolism |
3.6e-12 |
7 |
8.5 |
82 |
8 |
4566 |
phenylalanine catabolism |
3.6e-12 |
7 |
8.5 |
82 |
8 |
4566 |
fatty acid biosynthesis |
5.2e-12 |
10 |
12.1 |
82 |
25 |
4566 |
eicosanoid biosynthesis |
5.3e-12 |
9 |
10.9 |
82 |
18 |
4566 |
phenylalanine metabolism |
1.6e-11 |
7 |
8.5 |
82 |
9 |
4566 |
aromatic compound metabolism |
2.0e-10 |
9 |
10.9 |
82 |
25 |
4566 |
lipid biosynthesis |
4.6e-10 |
10 |
12.1 |
82 |
37 |
4566 |
catabolism |
5.5e-10 |
20 |
24.3 |
82 |
215 |
4566 |
oxidoreductase activity\, acting on the aldehyde or oxo group of donors\, NAD or NADP as acceptor |
1.4e-09 |
7 |
8.5 |
82 |
14 |
4566 |
mitochondrion |
2.0e-09 |
19 |
23.1 |
82 |
207 |
4566 |
oxidoreductase activity\, acting on the aldehyde or oxo group of donors |
7.8e-09 |
7 |
8.5 |
82 |
17 |
4566 |
response to xenobiotic stimulus |
7.9e-09 |
15 |
18.2 |
82 |
133 |
4566 |
response to chemical substance |
1.0e-08 |
22 |
26.8 |
82 |
308 |
4566 |
lyase activity |
7.0e-08 |
11 |
13.4 |
82 |
76 |
4566 |
lipase activity |
7.4e-08 |
6 |
7.3 |
82 |
14 |
4566 |
carboxylic ester hydrolase activity |
2.3e-07 |
7 |
8.5 |
82 |
26 |
4566 |
oxidoreductase activity\, acting on CH-OH group of donors |
2.9e-07 |
9 |
10.9 |
82 |
53 |
4566 |
oxidoreductase activity\, acting on the CH-OH group of donors\, NAD or NADP as acceptor |
2.9e-07 |
9 |
10.9 |
82 |
53 |
4566 |
energy pathways |
3.2e-07 |
16 |
19.5 |
82 |
200 |
4566 |
aldehyde dehydrogenase activity |
3.8e-07 |
5 |
6.0 |
82 |
10 |
4566 |
sulfur metabolism |
4.5e-07 |
16 |
19.5 |
82 |
205 |
4566 |
peroxisome |
6.7e-07 |
7 |
8.5 |
82 |
30 |
4566 |
phospholipase activity |
1.9e-06 |
5 |
6.0 |
82 |
13 |
4566 |
transferase activity\, transferring one-carbon groups |
3.7e-06 |
6 |
7.3 |
82 |
25 |
4566 |
photosynthesis |
4.6e-06 |
13 |
15.8 |
82 |
162 |
4566 |
response to toxin |
4.8e-06 |
6 |
7.3 |
82 |
26 |
4566 |
leukotriene biosynthesis |
6.4e-06 |
4 |
4.8 |
82 |
8 |
4566 |
prostanoid biosynthesis |
6.4e-06 |
4 |
4.8 |
82 |
8 |
4566 |
ribosome |
6.7e-06 |
14 |
17.0 |
82 |
194 |
4566 |
oxidoreductase activity\, acting on the CH-NH group of donors |
1.1e-05 |
4 |
4.8 |
82 |
9 |
4566 |
phospholipid metabolism |
1.1e-05 |
5 |
6.0 |
82 |
18 |
4566 |
electron transport |
1.4e-05 |
11 |
13.4 |
82 |
128 |
4566 |
phospholipase A2 activity |
2.2e-05 |
3 |
3.6 |
82 |
4 |
4566 |
carbon-oxygen lyase activity |
2.9e-05 |
6 |
7.3 |
82 |
35 |
4566 |
photosynthesis\, light reaction |
3.2e-05 |
10 |
12.1 |
82 |
115 |
4566 |
iron ion binding |
6.1e-05 |
4 |
4.8 |
82 |
13 |
4566 |
transaminase activity |
8.4e-05 |
4 |
4.8 |
82 |
14 |
4566 |
tricarboxylic acid cycle |
0.0001 |
4 |
4.8 |
82 |
15 |
4566 |